MARK SHEPTOFF FINANCIAL PLANNING, LLC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 1607355
GLASTONBURY, CT
Position in REGN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$62,354
-$14,910 QoQ
Shares Held
100
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#1,087
of 1,297 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARK SHEPTOFF FINANCIAL PLANNING, LLC holds $4,912,100 across 16 Biotechnology names. REGN ranks #4 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,295 | $4,617,105 | |
| 2 | DYN |
Dyne Therapeutics, Inc.
|
4,250 | $94,392 | |
| 3 | TVTX |
Travere Therapeutics, Inc.
|
1,600 | $90,896 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
100 | $62,354 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
160 | $12,523 | |
| 6 | ARQT |
Arcutis Biotherapeutics, Inc.
|
300 | $7,866 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
400 | $6,788 | |
| 8 | NVAX |
Novavax Inc
|
500 | $4,710 |
All Filings in REGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $62,354 | 100 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $77,264 | 100 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $77,187 | 100 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $56,227 | 100 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $52,500 | 100 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $63,423 | 100 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $71,233 | 100 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $105,124 | 100 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $141,889 | 135 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $96,249 | 100 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $87,829 | 100 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $82,296 | 100 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $71,854 | 100 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $82,167 | 100 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $72,149 | 100 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $103,330 | 150 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $88,669 | 150 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $104,763 | 150 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $94,728 | 150 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $90,777 | 150 | Shares | Sole | 2021-11-10 | |
| 2021-06-30 | $83,781 | 150 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $70,971 | 150 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $72,466 | 150 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $83,967 | 150 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $93,547 | 150 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $73,243 | 150 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||